Dewen Kong

739 total citations
12 papers, 553 citations indexed

About

Dewen Kong is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Dewen Kong has authored 12 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Complementary and alternative medicine. Recurrent topics in Dewen Kong's work include Traditional Chinese Medicine Analysis (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Flavonoids in Medical Research (2 papers). Dewen Kong is often cited by papers focused on Traditional Chinese Medicine Analysis (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Flavonoids in Medical Research (2 papers). Dewen Kong collaborates with scholars based in China and Canada. Dewen Kong's co-authors include Pavel Hamet, Jacques LeLorier, Parviz Ghadirian, Yijun Zhu, Weizhong Zhang, Junren Zhu, Lansheng Gong, Guanhua Du, Xiaoyue Zhao and Junke Song and has published in prestigious journals such as Molecules, Signal Transduction and Targeted Therapy and Journal of Hypertension.

In The Last Decade

Dewen Kong

11 papers receiving 530 citations

Peers

Dewen Kong

CCM

EDM

NEURO

Cheng Huan China

Alicia Sánchez-Mendoza Mexico

Maha A. Alamin Saudi Arabia

Danielle da Silva Dias Brazil

Soňa Čačányiová Slovakia

Thyago Moreira de Queiroz Brazil

Gustavo Pastelín-Hernández Mexico

Qiu-Yue Yi China

Nobuyuki Furutani Japan

Cheng Huan China

Dewen Kong

345 ×1.1

CCM

82 ×0.8

EDM

171 ×1.7

21 ×0.3

NEURO

42 ×0.8

Citations per year, relative to Dewen Kong Dewen Kong (= 1×) peers Cheng Huan

Countries citing papers authored by Dewen Kong

Since Specialization

Citations

This map shows the geographic impact of Dewen Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewen Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewen Kong more than expected).

Fields of papers citing papers by Dewen Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dewen Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewen Kong. The network helps show where Dewen Kong may publish in the future.

Co-authorship network of co-authors of Dewen Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Dewen Kong. A scholar is included among the top collaborators of Dewen Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewen Kong. Dewen Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yu, Haikuan, Chengcheng Zhang, Zhouguang Jiao, et al.. (2025). Epigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders. Frontiers in Pharmacology. 16. 1699296–1699296.

Kong, Dewen, Li Cao, Lingyan Ma, et al.. (2024). Identifying genetic targets in clinical subtypes of Parkinson’s disease for optimizing pharmacological treatment strategies. Signal Transduction and Targeted Therapy. 9(1). 320–320. 5 indexed citations

Kong, Dewen, Tianyi Yuan, Jian Zhou, et al.. (2023). Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways. Biomedicine & Pharmacotherapy. 168. 115837–115837. 28 indexed citations

Wang, Ranran, Dewen Kong, Ruiqi Liu, et al.. (2023). Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy. Biomedicine & Pharmacotherapy. 160. 114382–114382. 17 indexed citations

Kong, Dewen, Lida Du, Runzhe Liu, et al.. (2023). Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels. Acta Pharmacologica Sinica. 45(3). 480–489. 6 indexed citations

Zhang, Sen, Dewen Kong, Guodong Ma, et al.. (2022). Long-term administration of salvianolic acid A promotes endogenous neurogenesis in ischemic stroke rats through activating Wnt3a/GSK3β/β-catenin signaling pathway. Acta Pharmacologica Sinica. 43(9). 2212–2225. 31 indexed citations

Kong, Dewen, et al.. (2021). Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models. Acta Pharmaceutica Sinica B. 11(7). 1903–1913. 13 indexed citations

Zhao, Xiaoyue, Dewen Kong, Qimeng Zhou, et al.. (2021). Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway. Biomedicine & Pharmacotherapy. 140. 111556–111556. 80 indexed citations

Zhang, Li, Dewen Kong, Hongjuan Wang, et al.. (2021). Cocrystal of Apixaban–Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs. Molecules. 26(9). 2677–2677. 30 indexed citations

10.

Zhang, Wen, Junke Song, Wan Li, et al.. (2020). Salvianolic Acid D Alleviates Cerebral Ischemia-Reperfusion Injury by Suppressing the Cytoplasmic Translocation and Release of HMGB1-Triggered NF-κB Activation to Inhibit Inflammatory Response. Mediators of Inflammation. 2020. 1–15. 36 indexed citations

11.

Gong, Lansheng, Weizhong Zhang, Yijun Zhu, et al.. (1996). Shanghai trial of nifedipine in the elderly. Journal of Hypertension. 14(10). 1237–1245. 300 indexed citations

12.

Hamet, Pavel, Yu Sun, Danielle Malo, et al.. (1994). GENES OF STRESS IN EXPERIMENTAL HYPERTENSION. Clinical and Experimental Pharmacology and Physiology. 21(11). 907–911. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact